Stock Price Prediction

ZIMV stock closed at $13.84 on January 31, 2025, with a slight post-market increase to $13.85. Bulls may argue that ZIMV's focus on innovation, such as FDA-cleared GenTek components, positions it for long-term growth. However, its recent -2.33% regular market drop and volatility suggest cautious optimism around $14 as a potential recovery target.

ZIMV stock is bearish, trading at $13.85, down 2.33% on January 31, 2025. The decline reflects weak market sentiment and financial challenges, including a negative P/E ratio and recent volatility. Despite strategic efforts, the stock's near-term outlook remains pressured by limited profitability and market headwinds.

The market consensus for ZIMV's revenue in the upcoming quarter is projected to be approximately $118.964M USD.

The market consensus for ZIMV's eps in the upcoming quarter is projected to be approximately $0.221 USD.